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Background
It is increasingly recognised that effective anti-viral cell
mediated immunity depends not only on the frequency
of antigen specific T cells, but also on the quality of these
T cells. We have evaluated a vaccine protocol involving
DNA prime and Adenoviral vector boost to deliver SIV
gag in MHC typed Mauritian derived Macaca fascicularis.
Methods
Groups of 8 macaques were immunised 3 times on weeks
0, 4, 8 with 100μg purified plasmid DNA designed to
express SIVmac239 derived gag under the control of the
CMV immediate early promoter. Three different SIV gag
vaccines were compared. The DNA plasmids expressed
native SIVmac239gag, ubiquinated SIVmac239 gag or
fragmented, ubiquinated SIVmac239 gag derived peptides.
On week 19, the groups were boosted with 10e7 infectious
units recombinant Ad 5 expressing the same SIV Gag
antigens. Cell mediated immunity was assessed after each
immunisation and after virus challenge. At week 23, all
vaccinated macaques, along with a group of naive chal-
lenge controls began 10 weekly, atraumatic challenges via
the rectal mucosal with 150TCD50 SIVmac251.
Results
Delivery of this vaccine via the intra-dermal route elicited
CD8 and CD4 T cell responses. Moreover, approximately
50% of antigen specific CD4+ T cells expressed the
mucosal homing marker alpha4 beta7. When vaccinated
macaques were exposed to a stock of uncloned
SIVmac251 that had been propagated on simian PBMC’s,
by repeated low dose challenge via the intra-rectal route,
a significant delay (Wilcoxon test; p=0.015) in acquisition
of SIV was obtained amongst vaccinated macaques
compared with naive controls challenged in a similar
manner. Furthermore, peak viral loads amongst vacci-
nated macaques were significantly lower than challenge
controls (Kruskal-Wallis test; p=0.010).
Conclusion
We are investigating whether the route of immunisation
was crucial to the vaccine’s success.
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